Is DBECX or JNJ a better dividend investment in 2026?

DBECX currently yields 9.24% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: DBECX offers higher current income.

What is the dividend yield difference between DBECX and JNJ?

DBECX has a forward dividend yield of 9.24% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 5.88 percentage points.

Home › Compare › DBECX vs JNJ

DBECX vs JNJ: Dividend Comparison 2026

DBECX yields 9.24% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 DBECX wins by $16.8K in total portfolio value

INVESTMENT

TIME HORIZON10 years

DBECX

● Live price

9.24%

Share price

$21.64

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$36.9K

Annual income

$1,654.52

Full DBECX calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — DBECX vs JNJ

📍 DBECX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	DBECX	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, DBECX + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

DBECX pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DBECX

Annual income on $10K today (after 15% tax)

$785.58/yr

After 10yr DRIP, annual income (after tax)

$1,406.34/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, DBECX beats the other by $702.73/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DBECX + JNJ for your $10,000?

DBECX: 50%JNJ: 50%

100% JNJ50/50100% DBECX

Portfolio after 10yr

$28.4K

Annual income

$1,241.15/yr

Blended yield

4.36%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

DBECX

No analyst data

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DBECX buys

JNJ buys

No recent congressional trades found for DBECX or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricDBECXJNJ

Forward yield	9.24% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$36.9K ✓	$20.0K
Annual income after 10y	$1,654.52 ✓	$827.78
Total dividends collected	$12.9K ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: DBECX vs JNJ ($10,000, DRIP)

Year	DBECX Portfolio	DBECX Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$11,624	$924.21	$10,676	$355.77	+$948.00 → DBECX
2	$13,442	$1,004.04	$11,407	$389.39	+$2.0K → DBECX
3	$15,468	$1,085.09	$12,198	$426.53	+$3.3K → DBECX
4	$17,718	$1,166.96	$13,056	$467.62	+$4.7K → DBECX
5	$20,207	$1,249.24	$13,987	$513.12	+$6.2K → DBECX
6	$22,953	$1,331.56	$14,998	$563.56	+$8.0K → DBECX
7	$25,974	$1,413.56	$16,098	$619.52	+$9.9K → DBECX
8	$29,287	$1,494.92	$17,295	$681.69	+$12.0K → DBECX
9	$32,912	$1,575.33	$18,599	$750.82	+$14.3K → DBECX
10	$36,870	$1,654.52	$20,022	$827.78	+$16.8K → DBECX

DBECX vs JNJ: Complete Analysis 2026

DBECX — Stock

The fund normally invests at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities (or other instruments with similar economic characteristics) of companies located, organized, or with a majority of assets or business in emerging market countries, including other investment companies (underlying funds) that invest in such securities. It may uses a "fund of funds" approach by investing in one or more underlying funds and/or a "manager of managers" approach by selecting one or more experienced investment managers to serve as subadvisers to the fund.

Full DBECX Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this DBECX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DBECX vs SCHD DBECX vs JEPI DBECX vs O DBECX vs KO DBECX vs MAIN DBECX vs ABBV DBECX vs MRK DBECX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.